N

NervGen Pharma Corp.
D

NGEN

1.83500
USD
0.08
(4.26%)
مفتوح الان
حجم التداول
4,935
الربح لكل سهم
-0
العائد الربحي
-
P/E
-3
حجم السوق
197,304,032
المقالات
المزيد

العنوان: NervGen Pharma Corp.

القطاع: الرعاية الصحية
الصناعة: Biotechnology
NervGen Pharma Corp is a clinical-stage biopharmaceutical company developing first-in-class neuroreparative therapeutics for spinal cord injury and other traumatic and neurologic conditions. The Company's principal business activity is thediscovery, development and commercialization of neuroreparative therapeutics for spinal cord injury (SCI) and other neurotraumatic and neurologic conditions. NervGen's initial target indication is SCI. The company's pipeline products include NVG-291 and NVG-300.